Up a level |
Sarki, M and Ming, C and Aissaoui, S and Burki, N and Caiata Zufferey, Maria and Erlanger, T and Graffeo-Galbiati, R and Heinimann, K and Heinzelmann-Schwarz, V and Monnerat, C and Probst-Hensch, N and Rabaglio, M and Zürrer, U and Chappuis, P and Katapodi, M (2022) Differences in intention to inform relatives and rates of cascade testing in families concerned with hereditary breast and ovarian cancer and Lynch syndrome: The Swiss CASCADE cohort. In: European Human Genetics Conference, 11-14.6.2022, Wien.
Sarki, M and Ming, C and Aissaoui, S and Burki, N and Caiata Zufferey, Maria and Erlanger, T and Monnerat, C and Graffeo-Galbiati, R and Heinimann, K and Heinzelmann-Schwarz, V and Koechlin, H and Probst-Hensch, N and Rabaglio, M and Zürrer, U and Chappuis, P and Katapodi, M (2022) Intention to inform relatives, rates of cascade testing, and preference for patient-mediated communication in families concerned with hereditary breast and ovarian cancer and Lynch syndrome: The Swiss CASCADE cohort. Cancers, 14 (1636).
Katapodi, M and Viassolo, V and Caiata Zufferey, Maria and Nikolaidis, C and Bührer-Landolt, R and Bürki, N and Graffeo, R and Horváth, H and Kurzeder, C and Rabaglio, M and Scharfe, M and Urech, C and Erlanger, T and Probst-Hensch, N and Heinimann, K and Heinzelmann-Schwarz, V and Pagani, Olivia and Chappuis, P (2017) Swiss Cancer Predisposition Cascade Screening Consortium regarding the use and impact of genetic testing in hereditary breast/ovarian cancer and Lynch syndromes: the CASCADE study. Journal of Medical Internet Research. (In Press)